PD-L1 Antikörper (AA 19-238) (APC)
Kurzübersicht für PD-L1 Antikörper (AA 19-238) (APC) (ABIN1830297)
Target
Alle PD-L1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 19-238
-
Spezifität
- Human B7-H1.
-
Aufreinigung
- Protein G purified
-
Immunogen
-
Recombinant corresponding to aa19-238 from human B7-H1 expressed in NSO cell line.
Type of Immunogen: Recombinant protein -
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
Approved: Flo
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Saline, 0.5 % BSA, 0.1 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Do not freeze. Protect from light.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- May be stored at 4°C. For long-term storage, aliquot and store at 4°C. Do not freeze. Aliquots are stable for at least 1 year. Protect from light.
-
-
- PD-L1 (CD274 (PD-L1))
-
Andere Bezeichnung
- B7-H1 / PD-L1 / CD274
-
Hintergrund
-
Name/Gene ID: CD274
Synonyms: CD274, B7-H, B7 homolog 1, B7-H1, B7H1, CD274 Molecule, CD274 antigen, PDCD1 ligand 1, PDL1, PD-L1, PDCD1L1, PDCD1LG1, Programmed death ligand 1 -
Gen-ID
- 29126
-
UniProt
- Q9NZQ7
-
Pathways
- Cancer Immune Checkpoints
Target
-